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a b s t r a c t
Thiol oxidation is a probable outcome of cellular oxidative stress and is linked to degenerative disease
progression. In addition, protein thiol redox reactions are increasingly identified as a mechanism to reg-
ulate protein structure and function. We assessed the effect of hypothiocyanous acid on the cytoskeletal
protein tubulin. Total cysteine oxidation by hypothiocyanous and hypochlorous acids was monitored by
labeling tubulin with 5-iodoacetamidofluorescein and by detecting higher molecular weight inter-chain
tubulin disulfides by Western blot under nonreducing conditions. Hypothiocyanous acid induced nearly
stoichiometric oxidation of tubulin cysteines (1.9 mol cysteine/mol oxidant) and no methionine oxida-
tion was observed. Because disulfide reducing agents restored all the polymerization activity that was
lost due to oxidant treatment, we conclude that cysteine oxidation of tubulin inhibits microtubule poly-
merization. Hypothiocyanous acid oxidation of tubulin cysteines was markedly decreased in the presence
of 4% glycerol, a component of the tubulin purification buffer. Due to its instability and buffer- and pH-
dependent reactivity, hypothiocyanous acid studies require careful consideration of reaction conditions.
 2013 Elsevier Inc. All rights reserved.
Introduction
Our in vitro work with microtubule proteins including tubulin,
tau and microtubule-associated protein-2 (MAP-2) shows that cys-
teine oxidation to disulfides by peroxynitrite anion, hypochlorous
acid (HOCl)1 and other oxidants is associated with decreased micro-
tubule polymerization [1–3]. Tubulin, a heterodimer composed of
similar 50 kDa a- and b-subunits, contains 20 reduced cysteines
(12 in a-tubulin and 8 in b-tubulin) [4,5]. Because some tubulin cys-
teine oxidation (1–2 mol cys) by oxidants is tolerated before
microtubule polymerization is compromised, microtubule protein
thiols may protect other cellular targets from oxidation [1,6]. This
hypothesis is reinforced by our studies showing that the disulfides
in tubulin and microtubule-associated proteins are repaired by the
thioredoxin and glutaredoxin reductase systems thereby restoring
polymerization activity [1,7].
Though present in all cells, tubulin constitutes 10–15% of total
cellular protein in neurons [8,9]. Tubulin cysteine modifications
including oxidation to disulfides, S-glutathionylation and S-nitro-
sation, have been identified in several proteomics studies using cell
lines and tissue samples [10–13]. Recently, tubulin was identified
as a target for thiol oxidation by HOCl and chloramines in endothe-
lial cells [14].
In this study, we examine the effects of hypothiocyanous acid
(HOSCN) on purified porcine tubulin. HOSCN is a cellular oxidant
formed from thiocyanate ion (SCN) and H2O2 by peroxidases
including myeloperoxidase (MPO) and eosinophil peroxidase
[15,16]. HOSCN, like HOCl, oxidizes protein thiols and, if produced
in cells, will likely affect tubulin cysteines [17,18]. Our current
interest in HOSCN is twofold: (1) HOSCN is more selective for cys-
teines than other oxidants tested. Our published work over the
past decade has included oxidants that cause additional types of
damage–for example, methionine oxidation, S-nitrosation and
tyrosine nitration [3,6,19]. While Angeli’s salt is largely a cysteine
oxidant, presumably via release of HNO, it produces nitrite as a
byproduct which could yield nitrosation of cysteines. (2) MPO is
aberrantly expressed in Alzheimer’s disease brain [20,21]. More-
over, MPO immunoreactivity co-localized with neurofibrillary tan-
gles in neurons of Alzheimer’s disease brain and, 3-chlorotyrosine,
a marker of HOCl oxidation was detected. Based on these findings,
it is reasonable to hypothesize that HOSCN and HOCl could be
formed by MPO in AD neurons.
Our focus on tubulin allows us to categorize oxidants with
respect to their specificity for cysteine rather than other amino
acids. Total cysteine oxidation and effects on microtubule polymer-
ization by HOSCN and previously characterized oxidants, HOCl,
chloramines and Angeli’s salt, an HNO donor, are presented [3].
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Materials and methods
Materials
Porcine brains were obtained from Smithfield Packing Company
in Smithfield, Virginia. Angeli’s salt was from Cayman Chemicals
(Ann Arbor, MI). Bicinchoninic acid (BCA) protein assay reagent,
West Pico chemiluminescence detection system, Tris(2-carboxy-
ethyl)phosphine (TCEP) and 5-iodoacetomido-fluorescein (IAF)
were from Thermo Pierce. The mouse anti-b-tubulin antibody
(clone TUB 2.1) and the goat anti-mouse secondary antibody HRP
conjugate were from Sigma. All other chemicals were from Fisher
or Sigma. The concentration of HOCl was determined by measuring
the absorbance at 292 nm (e292 = 350 M1 cm1) in 0.1 M NaOH
[22]. A solution of Angeli’s salt was prepared immediately prior
to use in 0.01 M NaOH and stored on ice. Glycine chloramine was
prepared as described [3].
Preparation of hypothiocyanous acid
HOSCN was synthesized enzymatically in 0.1 M phosphate buf-
fer pH 6.4. A typical reaction (250 ll) contained 12.5 lg LPO,
1.2 mM KSCN and H2O2. After 15 min at 22 C, the reaction was
quenched with 500 U catalase. HOSCN was separated from LPO
and catalase using an Amicon Ultra centrifuge filter with a 10 K
cutoff. HOSCN was stored on ice and its concentration was deter-
mined using thionitrobenzoic acid (TNB). Under these conditions,
the concentration of HOSCN was 225–240 lM.
Purification of porcine brain tubulin
Tubulin was purified from porcine brain by two cycles of tem-
perature-dependent polymerization and depolymerization and
subsequent phosphocellulose chromatography as described [3].
Labeling of tubulin cysteines with IAF
Tubulin (6 lM, 120 lM cys) was diluted in either 0.1 M PB pH
7.4 or PME buffer pH 6.9 and then treated with each oxidant for
10 min at 22 C in a total reaction volume of 10–20 ll. Either
methionine or dichlorodimedone (200 lM) was added to quench
high HOCl concentrations. IAF (1.2 mM) in DMF was added to
achieve a 10-fold molar excess relative to protein cys and samples
were incubated at 37 C for an additional 30 min. Proteins were re-
solved by SDS–PAGE on 7.5% gels under reducing conditions and
gel images were captured using a Bio-rad Chemi-doc XRS imaging
system. The intensity of the fluorescein-labeled protein bands was
measured using Bio-rad Image Lab software. Alternatively, IAF-
labeled tubulin was precipitated with 80% ethanol, incubated on
ice for 20 min and the protein pellet was collected at 16,000g for
20 min. Pellets were washed twice with 80% ethanol and then
resuspended in 3 M guanidine HCl in 0.1 M Tris pH 8.8. Fluorescein
in each protein sample was quantitated at 490 nm relative to a
fluorescein standard curve prepared in 3 M guanidine HCl in
0.1 M Tris pH 8.8.
Detection of interchain disulfides by Western blot
Following treatment with oxidants as described above, tubulin
species (10–20 lg protein per lane) were separated by SDS–PAGE
on 7.5% polyacrylamide gels under nonreducing conditions. Pro-
teins were transferred to PVDF membranes, blocked with 3% milk
for 30 min and probed with a mouse monoclonal anti-b-tubulin
antibody (1:2000) for two hours. The b-tubulin/antibody complex
was detected using a goat anti-mouse HRP conjugate (1 h,
1:10,000) and Pierce West Pico chemiluminescent substrate.
Chemiluminescence was captured using the Bio-rad Chemi-doc
XRS imaging system.
Microtubule polymerization assays
Purified tubulin, diluted with PME or PB, was treated with up to
75 lM oxidant, for 10 min at 25 C (50 ll, 25 lM tubulin, 500 lM
cys). For repair assays, 1 mM DTT or TCEP was added for an addi-
tional 10 min at 22 C. GTP (1 mM final) was added to induce
polymerization and the samples were incubated at 37 C for 20–
25 min. Microtubule polymer was collected by centrifugation at
16,000g for 20 min. Control polymerization activity was set at
100% for those samples containing GTP but no oxidant. Controls
without GTP were used to establish 0% activity. Supernatant pro-
tein concentrations were determined by the BCA protein assay.
Protein supernatants were analyzed by SDS–PAGE with Coomassie
Blue staining. Protein pellets were dissolved in 6 M guanidine-HCl
and the absorbance was measured at 275 nm [1].
CNBr cleavage to detect methionine oxidation
Tubulin (12.5 lM, 250 lM cys, 325 lMmethionine) was treated
with each oxidant as described for IAF labeling above. Following
acidification to pH 2.5 with 70% formic acid, samples were treated
with 35–40 mM CNBr O.N. Samples were neutralized to pH 7.4–7.6
with NH4OH and subjected to SDS–PAGE under reducing condi-
tions on a 7.5% polyacrylamide gel. Proteins were transferred to
PVDF, blocked with 3% milk and incubated with mouse anti-
b-tubulin (1:2000) for 2 h. The tubulin-antibody complex was visu-
alized using a goat anti-mouse HRP conjugate (1:10000, 1 h) and a
chemiluminescent substrate.
Results and discussion
IAF labeling of tubulin cysteines
To assess oxidation of tubulin cysteines, we used the thiol-
specific reagent, iodoacetamido-fluorescein (IAF). Because IAF reacts
with reduced cysteines only, tubulin labeling will decrease as the
dose of oxidant increases. Previous work in our laboratory showed
that all 20 cysteines of tubulin, 12 in a- and 8 in b-tubulin, can be
labeled and are accessible without denaturants [1]. Fig. 1A shows
that labeling of both a- and b-tubulin decreased as the concentra-
tion of oxidant, HOSCN or HOCl, increased. This is typical of the
oxidants we have studied and no subunit specificity has been
observed [3,6,19].
The tubulin preparation used in Figs. 1 and 2 was desalted to
remove small molecules present during purification including un-
bound GTP, glycerol, EGTA and Mg2+. This tubulin was exchanged
into PB pH 7.4 because this buffer does not react with oxidants.
These methods, including the buffers and ratios of oxidant to tubu-
lin cys are consistent with those we have performed in our studies
of tubulin oxidation by ONOO, NO donors, H2O2, HOCl and chlor-
amines [1,3,19,23,24].
In Fig. 1A, tubulin (120 lM cys) was treated with increasing
concentrations of HOCl and HOSCN. As the concentration of oxi-
dant increased, labeling with IAF decreased. Neither thiocyanate
ion alone nor decomposed HOSCN affected IAF labeling (Fig. 1S).
The concentrations of HOCl used were greater than those of HOSCN
and yet, more oxidation was observed with HOSCN. To ensure that
no oxidant remained, we performed time-course experiments with
HOSCN and the reaction was essentially complete after 5 min (Sup-
plemental data Fig. 2S). In the case of 100 lM HOCl treatment,
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200 lM methionine or monochlorodimedone was added to scav-
enge any remaining oxidant.
Our data is consistent with published work showing that HOS-
CN is a more selective cysteine oxidant than HOCl [17,18]. The
highest concentration of HOSCN used was 50 lM and given the
tubulin cysteine concentration (120 lM) and the ratio of two cys
oxidized per HOSCN, lane eight in Fig. 1A shows nearly stoichiom-
etric cysteine oxidation. We and others have determined that all
cysteines of tubulin are accessible to thiol reagents without addi-
tion of denaturants [23,24]. Fluorescein incorporation into precip-
itated tubulin pellets was quantitated at 490 nm vs. a fluorescein
standard curve (Fig. 1B). Using this method and the same concen-
trations of tubulin and oxidants, 25 and 50 lM HOSCN oxidized 46
and 95 lM tubulin cys, respectively which is consistent with the
IAF labeling in Fig. 1A. Given that HOSCN was always substoichio-
metric with respect to tubulin cysteines (50 lM HOSCN and
120 lM cys), it is unlikely that tryptophan residues of tubulin were
oxidized [25]. Given the 1.9:1 stoichiometry (mol cys/mol HOSCN)
that is observed, residual RS-SCN would not be expected.
HOSCN was compared to other oxidants that we have examined
in addition to HOCl. Fig. 1C shows oxidation of tubulin (120 lM
cys) by 50 lM HOSCN, glycine chloramine (GC), HOCl and H2O2.
The concentration of oxidant used was substoichiometric relative
to protein cys and no HOSCN, HOCl or GC remained in solution
after 10 min. In addition to time course experiments, we deter-
mined that no oxidant remained using TNB. When TNB was added
to the reactions after 10 min, no TNB absorbance change was ob-
served. In the case of H2O2, catalase was added to ensure that no
oxidant remained.
HOSCN was the most effective cysteine oxidant followed by GC/
HOCl and H2O2 (Fig. 1C and D). This is consistent with our previous
work showing that GC was similar in reactivity to HOCl with tubu-
lin cysteines [3]. However, we did observe that taurine chloramine
was more selective for tubulin cysteines than GC [3]. Peskin and
Winterbourn observed that taurine chloramine was a more selec-
tive cysteine oxidant than HOCl [26,27]. This ranking of oxidants
was confirmed using absorbance data for identical oxidant-treated
and IAF-labeled samples that were precipitated with ethanol and
resuspended in guanidine HCl (Fig. 1D). Analysis of the data in
Fig. 1D showed no statistical difference between GC and HOCl.
IAF is specific for cysteines and no other amino acids are labeled
under the conditions employed (Fig. 1E and Supplemental data
Fig. 1. Modification of tubulin cysteines by HOSCN and other oxidants (A). Tubulin (6 lM, 120 lM cys) in 0.1 M phosphate pH 7.4 was treated with 25, 50 and 100 lM HOCl
or 10, 25 and 50 lMHOSCN for 10 min. at 22 C. After treatment with 1.2 mM IAF for 30 min at 37 C, samples were subjected to SDS–PAGE under reducing conditions on 7.5%
polyacrylamide gels. Gel images were captured using Bio-rad Chemi-doc XRS imaging system. (B) Reaction conditions were identical to A. Tubulin samples were precipitated
in 80% ethanol and fluorescein incorporation was quantitated at 490 nm. These data represent the mean ± standard error of three independent experiments. One-way ANOVA
with Tukey post hoc test showed that each concentration of HOSCN and HOCl assayed was significant p < 001 (C) tubulin (6 lM, 120 lM cys) in 0.1 M phosphate pH 7.4 was
treated with 50 lM HOSCN, GC, HOCl or H2O2 for 10 min at 22 C. After treatment with 1.2 mM IAF for 30 min at 37 C, samples were subjected to SDS–PAGE under reducing
conditions on 7.5% polyacrylamide gels. (D) Reaction conditions were identical to C. Tubulin samples were precipitated in 80% ethanol and fluorescein incorporation was
quantitated at 490 nm. These data represent the mean ± standard error of three independent experiments. One-way ANOVA with Tukey post hoc tests showed that all
oxidants decreased IAF labeling relative to control P < 001. HOSCN was most effective and HOCl and GC were equivalent. (E) Tubulin (6 lM, 120 lM cys) in 0.1 M phosphate
pH 7.4 was treated with oxidant or TCEP for 10 min at 22 C. (Lane 1, control; lane 2, control + 5 mM TCEP; lane 3, 25 lM HOSCN; lane 4, 25 lM HOSCN followed by 5 mM
TCEP; lane 5) 1.2 mM IAM for 30 min. After treatment with 1.2 mM IAF for 30 min at 37 C, samples were subjected to SDS–PAGE under reducing conditions on 7.5%
polyacrylamide gels.
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Fig. 3S). The oxidant-induced decrease in IAF labeling that we ob-
served in Fig. 1A–D was reversible when the disulfide reducing
agent TCEP was added after oxidant treatment. IAF labeling of oxi-
dized tubulin was restored to control levels by TCEP (Fig. 1E). We
chose to use TCEP because it is a phosphine, not a thiol-based
reducing agent like DTT. Therefore, it can be present during the
IAF labeling step.
In addition, pretreatment of tubulin with iodoacetamide (IAM)
abolished IAF labeling (Fig. 1E–lane 5) thereby confirming that
IAF is specific for thiols and does not bind nonspecifically to tubu-
lin. An additional IAM-blocking experiment and the corresponding
Coomassie-stained gel image are presented in the Supplemental
data (Fig. 3S).
Western blot detection of tubulin inter-chain disulfides
In addition to IAF labeling, we employed a Western blot method
to assess cysteine oxidation of tubulin. Oxidation of tubulin cyste-
ines yields higher molecular weight disulfide-linked species that
can be resolved by SDS–PAGE under non-reducing conditions.
Tubulin dimers and tetramers are formed as well as larger oligo-
mers that do not enter the separating gel. Previous work from
our laboratory confirmed that the addition of reducing agents such
as b-mercaptoethanol, DTT and TCEP abolish all higher molecular
weight tubulin species including those in the sample wells [1,6].
In Fig. 2A, tubulin (200 lM cys) was treated with 50 and
100 lM HOCl and Angeli’s salt, an HNO donor, and 25 and 50 lM
HOSCN. As tubulin was oxidized to higher molecular weight spe-
cies, the b-tubulin band at 50 kDa decreased in intensity. Likewise
the bands observed near the top of the blot increased. This upper
band is near the interface of the stacking and separating gels. This
top band was not as apparent for tubulin treated with 50 lM HOS-
CN (lane 6) even though the 50 kDa b-tubulin band is the lightest
on this blot. Additional blots, in which any tubulin in the sample
wells was transferred, showed that the greatest b-tubulin antibody
reactivity was in the wells of those samples treated with HOSCN.
Control tubulin in lane 7 of Fig. 2A did not contain a reducing
agent whereas control tubulin in lane 8 was treated with DTT. Con-
trol tubulin stored in the absence of a reducing agent always con-
tains trace amounts of dimers due to air-oxidation (lane 7) [6]. The
two faint dimer bands run at slightly different sizes because brain
tubulin is composed of multiple a- and b-tubulin gene products
yielding a heterogeneous mixture of proteins [28].
The greatest extent of tubulin cysteine oxidation to higher
molecular weight disulfides was observed with HOSCN even
though lower concentrations of HOSCN were used relative to HOCl
or Angeli’s salt. The HOCl results are consistent with the IAF label-
ing results in Fig. 1A–D. Because changes in the b-tubulin band
intensity at 50 kDa only represent inter-subunit disulfides, it is
not possible to quantitate total cysteine oxidation based on the
Western blot results. Our qualitative data comparing HOSCN and
HOCl by this method and our quantitative data by IAF labeling
demonstrate that HOSCN is a more selective oxidant of cysteine
residues in tubulin than HOCl.
Coomassie staining of oxidized tubulin
Because the Western blot in Fig. 2A only showed oxidation of b-
tubulin, and because Western blots with a-tubulin displayed con-
siderable smearing, we have developed another method to assess
tubulin cysteine oxidation. Furthermore, we were concerned about
antibody binding and effective transfer to PVDF given the forma-
tion of very high molecular weight disulfide-linked species follow-
ing HOSCN treatment.
Tubulin samples were oxidized, treated with IAM to modify any
free cysteines and separated by SDS–PAGE under nonreducing con-
ditions. The Coomassie-stained samples in Fig. 2B are identical to
those in Fig. 2A. In addition to the a- and b-tubulin bands which
decreased in intensity as oxidation increased, tubulin was detected
in the wells of those lanes that contained oxidant-treated tubulin
(lanes 1–6). In addition, tubulin was observed at the interface be-
tween the stacking and separating gels. This is different from the
controls in lanes 7 and 8 where MAP-2, a minor microtubule-
associated protein contaminant was detected. Because both the
a- and b-tubulin bands in Fig. 2B decreased as oxidation increased,
both subunits must comprise the higher molecular weight,
disulfide-linked tubulin species detected by Western blot in
Fig. 2A. Given that the mobility of the MAP2 contaminant also
changed, this result suggests that it too is oxidized to higher
molecular weight species.
Effect of oxidants on tubulin polymerization
To assess the effect of oxidants on tubulin polymerization, we
oxidized protein samples and then induce polymerization with
GTP at 37 C. Polymerization assays require a much higher
concentration of tubulin (25 lM and 500 lM cys) relative to
the oxidation studies in Figs. 1 and 2 (120–200 lM cys). Further-
more, due to the instability of HOSCN and its relatively low con-
centration following synthesis, the highest dose of HOSCN and
HOCl tested was 75 lM. The ratio of oxidant to tubulin cys is
important because, in previous work, we determined that some
cysteine oxidation is tolerable before polymerization activity is
compromised [1,6].
Tubulin polymerization yields a microtubule polymer that can
be collected by centrifugation. If polymerization is inhibited by
oxidants, the tubulin concentration in the supernatant will in-
crease. In addition, equal volumes of supernatants were subjected
to SDS–PAGE with Coomassie staining to determine the extent of
Fig. 2. Detection of higher molecular weight tubulin disulfides by Western blot and
Coomassie stain (A). Tubulin (10 lM, 200 lM cys) was treated with 50 and 100 lM
HOCl and Angeli’s salt or 25 and 50 lM HOSCN for 10 min at 22 C. C is control
tubulin without a reducing agent whereas C + contained bME. For Western blot
detection, oxidized tubulin species were separated by SDS–PAGE under nonreduc-
ing conditions, transferred to PVDF and probed with anti-b-tubulin. Monomeric
b-tubulin (50 kDa) is labeled as well as dimers and oligomers. (B) Tubulin samples
were identical to those in A. Prior to SDS–PAGE under nonreducing conditions,
samples were treated with 50 mM iodoacetamide. Protein bands were stained with
Coomassie blue and photographed.
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polymerization. This is especially important if polymerization sam-
ples contain reducing agents because they interfere with the BCA
assay. Lastly, the amount of microtubule protein in the pellet
was measured at 275 nm and compared to control samples to
determine polymerization activity.
Table 1 shows that tubulin treated with 75 lM HOSCN and
HOCl resulted in decreased polymerization activity. Inhibition of
polymerization by HOSCN was greater than by HOCl at both 50
and 75 lM. However, the difference was minimal with 71% of con-
trol activity in those samples treated with 75 lM HOSCN vs. 76% of
control activity in the 75 lM HOCl samples. SDS–PAGE and Coo-
massie staining of the resulting supernatants consistently showed
more protein in the HOSCN samples compared to the HOCl sam-
ples. As expected, the protein pellets obtained for the HOSCN-
treated samples contained slightly more protein than the HOCl-
treated samples.
A particular challenge in this work was the comparison of HOS-
CN and HOCl given that HOSCN was synthesized enzymatically in
phosphate buffer at pH 6.4. The lower pH was required to maxi-
mize synthesis of HOSCN; however, tubulin polymerization
in vitro is typically performed in PME buffer pH 6.9 [18]. Controls
showed that polymerization was reduced in phosphate buffer at
all pH values tested (6.4, 6.9 and 7.4). In addition, the concentra-
tion of HOSCN was typically 225–240 lM and therefore, relatively
large volumes of HOSCN in PB pH 6.4 were combined with tubulin
in PME pH 6.9. To correct for these buffer differences, HOCl was di-
luted in PB pH 6.4 and control polymerization assays contained
mixtures of PME and PB.
Of note, samples treated with the oxidants and then with DTT
prior to the addition of GTP, contained the same amount of pellet
protein as controls that did not contain oxidants and DTT. This is
important because it shows that reduction of disulfides restored
all polymerization activity and that cysteine oxidation was respon-
sible for inhibition. In previous work from our laboratory, higher
doses of HOCl yielded greater cysteine oxidation and lost polymer-
ization activity was not fully restored with a reducing agent [3].
We hypothesized that oxidation and reduction altered protein
structure such that some fraction of tubulin was rendered non-
functional. Thiocyanate ion alone did not inhibit polymerization
nor did decomposed HOSCN.
Given the results in Figs. 1 and 2 confirming that HOSCN is a
much more effective cysteine oxidant than HOCl, the polymeri-
zation results in Table 1 were perplexing. Careful consideration
of the tubulin preparations used in Figs. 1 and 2 vs. Table 1 sug-
gested a possible explanation. Tubulin is purified from brain tis-
sue by cycles of temperature-dependent polymerization and
depolymerization followed by phosphocellulose column chroma-
tography to remove microtubule-associated proteins. In addition
to PME buffer, some GTP and glycerol is present following puri-
fication. It is this PME-tubulin that was used for polymerization
assays whereas portions of PME-tubulin were desalted into
phosphate buffer pH 7.4 for the assays in Figs. 1 and 2
(PB-tubulin).
To address this discrepancy, we treated PME-tubulin, used for
polymerization assays, with HOSCN and HOCl using the same
protein to oxidant ratio as employed in our polymerization studies
(Table 1). The IAF labeling results showed that both HOSCN and
HOCl oxidized cysteines; however, the differences between the
two oxidants are not as striking as in Fig. 1A–D). Quantitation of
band intensities showed that 75 lM HOSCN oxidized 1.2 mol cys/
mol oxidant whereas 75 lM HOCl oxidized 1.0 mol cys/mol
oxidant.
Buffer and glycerol effects on HOSCN oxidation of tubulin
To determine which component of the PME-tubulin preparation
interfered with cysteine oxidation by HOSCN, we systematically
added the buffer components: PIPES, Mg2+ and EGTA to PB-tubulin
prior to the addition of HOSCN. In addition, we tested the ability of
GTP and glycerol to infer with tubulin cysteine oxidation by
HOSCN.
Although a slight difference in oxidation was observed with
PIPES vs. PB, the presence of as little as 1.5% glycerol decreased
HOSCN oxidation of tubulin in PME. These results are shown in
Fig. 3A. The samples in lanes 1–4 contained tubulin in PB whereas
those in lanes 5–8 contain tubulin in a mixture of phosphate and
PIPES buffers. Greater oxidation of tubulin by HOSCN is observed
in lane 6 for the PIPES/phosphate sample vs. the phosphate-only
sample in lane 2 indicative of a buffer effect. This is not unexpected
given that HOSCN is unstable and its half-life varies in a pH-
dependent manner [15,17,29]. Tubulin samples in lanes 7 and 8
were identical to lane 6 except they contained 1.5% and 4% glyc-
erol, respectively. The much darker a- and b-tubulin bands are
indicative of less tubulin oxidation to higher molecular weight spe-
cies. For the tubulin samples oxidized by HOSCN in phosphate buf-
fer (lanes 2–4), the 4 % glycerol sample showed decreased tubulin
cysteine oxidation (lane 4) but the 1.5% sample had only a modest
effect.
Table 1
Effect of HOSCN and HOCl on cysteine oxidation and microtubule polymerization.
Polymerization assays contained 25 lM tubulin (500 lM cys) and 75 lM oxidant in
PME-tubulin. Cysteine oxidation of PB-tubulin was assessed by IAF labeling as
described in Fig. 1 using 100–150 lM tubulin cys and up to 75 lM oxidant. PME-
tubulin was diluted to the same ratio of tubulin cys to oxidant. Band intensities were
used to calculate mol cys/mol oxidant.
Oxidant % Polymerization activity Cysteine oxidation (mol cys/mol
oxidant)
PB-tubulin PME-tubulin
HOSCN 71 ± 3 1.9 ± 0.1 1.2 ± 0.2
HOCl 76 ± 2 0.9 ± 0.2 1.0 ± 0.2
Fig. 3. Effect of buffer and glycerol on tubulin cysteine oxidation by HOSCN and
HOCl (A). Tubulin (6 lM, 120 lM cys) was treated with 25 lM HOSCN in 0.1 M
phosphate pH 7.4 (lanes 1–4) or phosphate plus PME (lanes 5–8) for 10 min at
22 C. In addition to HOSCN, samples in lanes 3 and 7 contained 1.5% glycerol
whereas those in lanes 4 and 8 contained 4% glycerol. Controls are shown in lanes 1
and 5. (B) Tubulin (6 lM, 120 lM cys) was treated with 50 lM HOSCN (lane1) or
HOCl (lane 4) in 0.1 M phosphate pH 7.4 for 10 min at 22 C. Samples in lanes 2 and
5 contained 4% glycerol in addition to oxidant. C is control tubulin. Prior to SDS–
PAGE under nonreducing conditions on 7.5% gels, samples were treated with
50 mM iodoacetamide. Protein bands were stained with Coomassie blue and
photographed.
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We hypothesized that glycerol decreased tubulin oxidation by
HOSCN due to changes in solution viscosity and hydrogen-bonding
capacity. Alterations in hydrogen-bonding networks on the surface
of tubulin by glycerol could limit accessibility to thiols by oxidants
and labeling reagents. Because HOSCN is a short-lived oxidant with
a half-life of 42 min at pH 6.5, it is possible that glycerol impedes
its interaction with tubulin cysteines [17,29].
Experiments with TNB, a small molecule thiol, were performed
to determine if glycerol decreased HOSCN oxidation. No glycerol
effect was observed with up to 10% glycerol. However, 4% glycerol
hindered control IAF labeling of cysteines in the model proteins,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and creatine
kinase. IAF labeling of control GAPDH and creatine kinase de-
creased by 23% and 20%, respectively in the presence of 4% glycerol
(Supplemental data Fig. 4S). While it is clear that IAF labeling of
unoxidized GAPDH and creatine kinase was affected by 4% glycerol,
interpretation of changes in HOSCN oxidation are unclear.
To confirm a glycerol effect for HOSCN, but not for HOCl, we
treated tubulin with each oxidant in the presence and absence of
4% glycerol. Fig. 3B clearly shows the difference in tubulin oxida-
tion by HOSCN when glycerol was present (lanes 1 vs. 2). However,
no appreciable difference in tubulin oxidation by HOCl was ob-
served in lanes 3 vs. 4. This result is consistent with the data in
Table 1 showing nearly equivalent cysteine oxidation of PME-
tubulin and correspondingly similar inhibition of tubulin polymer-
ization by the two oxidants.
Cyanogen bromide cleavage assay to detect methionine oxidation
We had previously shown that HOCl and chloramines oxidized
tubulin methionines using a cyanogen bromide (CNBr) cleavage as-
say [3]. Therefore we wanted to confirm that tubulin methionines
were not oxidized by HOSCN. Controls were performed in the pres-
ence of excess thiocyanate to ensure that the ion did not interfere
with CNBr cleavage. Tubulin treated with HOSCN was fragmented
to the same extent as tubulin that had not been oxidized (Fig. 4).
While it is apparent that HOSCN does oxidize tubulin cysteines,
the kinetics and pH dependence of the reaction are complex.
Kinetic data shows that HOSCN, not OSCN, reacts with protein thi-
olates (RS) [17]. Given that the HOSCN pKa is 5 (both 5.3 and
4.85 have been reported) and most thiols have pKa values of 8–9,
pH, buffer choice and even ionic strength can have a great effect
on HOSCN reactivity [15,17]. Furthermore, HOSCN is unstable
and decomposes with pH-dependent half-life of 42.5 min at pH
6.5 [29].
All 20 cysteines of tubulin 12 in a- and 8 in b-tubulin, can be
labeled by thiol reagents [23,24]. However, no detailed study of
their pKa values has been reported and it is assumed that pKa val-
ues are typical of the amino acid cysteine (8.5–9). Of note, Britto
et al. have identified two classes of tubulin cysteines, slow- and
fast-reacting but they could not be distinguished with iodoaceta-
mide-based reagents. Further, Britto et al. examined the 3.5 Å
electron diffraction structure of tubulin and identified some posi-
tively charged amino acids in proximity to cysteines [23]. They
hypothesize that such a positive charge could stabilize a thiolate
thereby enhancing reactivity with electrophiles and possibly with
oxidants.
Our results herein and in previous work do not support
selective oxidation of tubulin cysteines. We routinely check for
selectively with each oxidant by trypsin digestion of IAF-labeled
tubulin. We observe that as the concentration of oxidant increases,
all IAF labeled peptide peaks decrease suggesting partial oxidation,
and therefore similar reactivity of tubulin cysteines.
HOSCN is the most selective tubulin cysteine oxidant we have
identified to date. Of all the oxidants we have tested previously,
only Angeli’s salt, an HNO donor, is specific for cysteine. However,
the rate of HNO release is also dependent on reaction conditions
and the half-life of Angeli’s salt is only 2.3 min at 37 C in 0.1 M
phosphate buffer pH 7.4 [30]. Thus, the effective dose of HNO from
Angeli’s salt is dependent on reaction conditions. Given that all the
oxidants tested have the potential to form in cells, our findings are
important in both understanding the outcome of cellular oxidative
stress and in understanding tubulin reactivity in vitro.
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